Eurofins Launches Rapidust® - a Patented on-Site Sampling & Analysis System for Mycotoxins in Grains to Offer Grain Industry...
November 12 2014 - 3:21AM
Business Wire
Regulatory News:
Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in
food and feed testing, announces the launch of rapidust®, the first
on-site test system for mycotoxins, including both representative
sampling of grain lots and rapid analysis, to provide broader risk
protection across the grain industry regarding mycotoxin
contaminations.
Representative sampling is the key success factor for the
correct assessment of a grain lot, as mycotoxins usually occur
heterogeneously distributed throughout the lot. Reliable results at
reasonable time effort are crucial to allow for fast and effective
quality management in grain trading and processing. The rapidust®
system entirely fulfills these requirements.
In contrast to conventional time- and labour-intensive grain
sampling methods, the patented rapidust® procedure1 is based on
dust sampling and analysis. Based on the proven fact that the
contamination of the overall grain lot and its dust particles can
be correlated, Eurofins now offers its customers unique certainty
on the mycotoxin contamination of large grain lots within minutes.
Representative dust samples can be easily taken with the mobile or
fixed process integrated rapidust® sampling device, wherever grain
is handled and transported – at the lorry, silo, ship or as an
in-process control. Without any grinding the dust is directly
extracted and analysed on-site by means of the rapidust® test kits.
The results are immediately and reliably calculated for the entire
grain lot by the rapidust® app. Thanks to an easily understandable
traffic-light system, fast decisions on approval of grain lots and
process control can be taken.
The rapidust® service is rounded off with customised system
installation services, conventional on-site sampling services and
the full access to the comprehensive portfolio of screening and
confirmatory methods in the Eurofins laboratories under DIN EN
ISO/IEC 17025:2005 accreditation.
With rapidust® Eurofins complements its comprehensive lab-based
Risk-Orientated Mycotoxin and Biotoxin Testing2 package with an
on-site product portfolio. Entering into the first test market
Eurofins now offers customers full service for mycotoxin management
along the grain value chain.
The Group’s Competence Centre for Mycotoxin and Biotoxin Testing
in Hamburg has been a pioneer in developing highly sensitive and
innovative methods for trace amount detection of mycotoxins and
biotoxins in food and feed for more than 20 years.
1 Eurofins rapidust® Mycotoxins Brochure:
http://www.eurofins.de/media/10315289/rapidust_brochure_en.pdf2
Eurofins Risk-orientated Mycotoxin and Biotoxin Testing :
http://www.eurofins.de/media/2591359/Mycotoxins_ENG.pdf
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific is the world leader in food and pharmaceutical products
testing. It is also number one in the world in the field of
environmental laboratory services and one of the global market
leaders in agroscience, genomics, discovery pharmacology and
central laboratory services.
With 16,000 staff in more than 200 laboratories across 36
countries, Eurofins offers a portfolio of over 100,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products. The Group provides its customers with
high-quality services, accurate results in time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the data
available to the Company as of the date of publication, but no
guarantee can be made as to their validity.
Dr. Scarlett BiselliEurofins WEJ Contaminants GmbHPhone: +49 40
49 294 2002Email: scarlettbiselli@eurofins.deorEurofins Investor
RelationsPhone: +32 2 766 1620Email: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024